- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: valproate acid.
Displaying page 1 of 2.
EudraCT Number: 2006-001443-63 | Sponsor Protocol Number: 01062 | Start Date*: 2006-07-10 |
Sponsor Name:European Lung Cancer Working Party | ||
Full Title: A phase II study assessing the activity of valproate acid plus doxorubicin in refractory or recurrent malignant mesothelioma. | ||
Medical condition: This is a prospective phase II study investigating well-known antimetabolite (doxorubicin) and antiepileptic (valproate) drugs, in combination, for the treatment of refractory or recurrent malignan... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006773-92 | Sponsor Protocol Number: FARM6TT8SP | Start Date*: 2008-07-23 | ||||||||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI PERUGIA | ||||||||||||||||||
Full Title: Sodium Valproate in the treatment of medication overuse headache: a controlled randomized clinical trial. | ||||||||||||||||||
Medical condition: medication overuse headache | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004278-41 | Sponsor Protocol Number: 01081 | Start Date*: 2010-04-19 |
Sponsor Name:Institut Jules Bordet | ||
Full Title: A phase II study of doxorubicin, cyclophosphamide and vindesine with valproic acid in patients with refractory or relapsing small cell lung cancer after platinum derivatives and etoposide. | ||
Medical condition: This is a prospective phase II study investigating well-known chemotherapeutic (doxorubicin, cyclophosphamide, vindesine) and antiepileptic (valproate) agents, in combination, for the treatment of... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001339-41 | Sponsor Protocol Number: N01175 | Start Date*: 2004-12-22 | |||||||||||
Sponsor Name:UCB S.A. Pharma Sector | |||||||||||||
Full Title: A therapeutic confirmatory, open-label, multi-center, randomized 2 parallel groups, community-based trial studying the efficacy and safety of levetiracetam (1000 to 3000 mg/day oral tablets 250-50... | |||||||||||||
Medical condition: Monotherapy in subjects with newly diagnosed epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) FI (Completed) SE (Completed) SK (Completed) IE (Completed) CZ (Completed) GB (Completed) DE (Completed) BE (Completed) ES (Completed) IT (Completed) HU (Completed) PT (Not Authorised) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000869-11 | Sponsor Protocol Number: NC200601 | Start Date*: 2006-12-20 | |||||||||||
Sponsor Name:Neuro-Consil GmbH | |||||||||||||
Full Title: Comparison of efficacy and tolerability of rapid intravenous infusion of levetiracetam and sodium valproat. | |||||||||||||
Medical condition: Focal epilepsy requiring rapid initiation of anticonvulsant protection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001637-88 | Sponsor Protocol Number: 2014-650 | Start Date*: 2014-08-12 | |||||||||||
Sponsor Name:John Vissing | |||||||||||||
Full Title: A phase 2a study to explore treatment with Sodium Valproate in adults with McArdle Disease (Glycogen Storage Disorder Type V, GSDV) | |||||||||||||
Medical condition: McArdle disease (Glycogen storage disorder type V) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004091-35 | Sponsor Protocol Number: EMC-NET1 | Start Date*: 2019-04-19 | |||||||||||||||||||||
Sponsor Name:Erasmus University Medical Center | |||||||||||||||||||||||
Full Title: Improving Treatment Options for Somatostatin Type 2 Receptor Negative Neuroendocrine Tumor Patients | |||||||||||||||||||||||
Medical condition: Neuroendocrine tumors | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011723-31 | Sponsor Protocol Number: VPA-study | Start Date*: 2009-12-09 | |||||||||||
Sponsor Name:Västra Götalandsregionen | |||||||||||||
Full Title: Effects of valproic acid on fibrinolysis in man | |||||||||||||
Medical condition: This is a healthy volunteer trial. The intended indication for the product is to investigate if upregulation of the tPA-gene by valproic acid results in increased tPA-release from endothelium in f... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: SE (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003927-11 | Sponsor Protocol Number: A7501008 | Start Date*: 2005-08-04 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or ValproicAcid/Divalproex Sodium for the Treatment of... | |||||||||||||
Medical condition: Bipolar 1 Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005345-19 | Sponsor Protocol Number: R076477BIM3003 | Start Date*: 2006-05-25 |
Sponsor Name:Janssen-Cilag International N.V. | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood S... | ||
Medical condition: Bipolar I Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: EE (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001472-12 | Sponsor Protocol Number: A7501009 Amendment 1 | Start Date*: 2006-04-12 | |||||||||||
Sponsor Name:N V Organon | |||||||||||||
Full Title: A Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing Trial A7501008 and Continuing Lithium or Valproic Acid/Divalp... | |||||||||||||
Medical condition: Bipolar I Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002939-18 | Sponsor Protocol Number: GWEP1447 | Start Date*: 2016-04-29 | |||||||||||
Sponsor Name:GW Research Ltd. | |||||||||||||
Full Title: A phase 2, double-blind, randomized, placebo-controlled pharmacokinetic trial in two parallel groups to investigate possible drug- drug interactions between stiripentol or valproate and GWP42003-P ... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003834-40 | Sponsor Protocol Number: 07NR07 | Start Date*: 2008-10-31 | |||||||||||
Sponsor Name:UCL-INSTITUTE OF CHILD HEALTH | |||||||||||||
Full Title: THE IMPACT OF REDUCING OVERTREATMENT ON QUALITY OF LIFE IN CHILDREN WITH REFRACTORY EPILEPSY | |||||||||||||
Medical condition: We are studying a population of children with refractory epilepsy. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002933-12 | Sponsor Protocol Number: 11/0090 | Start Date*: 2014-04-07 | |||||||||||
Sponsor Name:University College London, | |||||||||||||
Full Title: A Phase II pilot study to explore treatment with Sodium Valproate in Adults with McArdle Disease (Glycogen Storage Disorder Type V, GSDV) | |||||||||||||
Medical condition: McArdle disease (Glycogen storage disease type V, GSDV). The condition is an inherited disorder of skeletal muscle that causes exercise intolerance. The condition can give way to potential rhabdom... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001981-41 | Sponsor Protocol Number: BALANCE Trial | Start Date*: 2005-01-24 | |||||||||||
Sponsor Name:UNIVERSITY OF OXFORD | |||||||||||||
Full Title: Bipolar Affective disorder: Lithium/ANti-Convulsant Evaluation | |||||||||||||
Medical condition: Maintenance treatment of bipolar disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000550-75 | Sponsor Protocol Number: RG_05-004 | Start Date*: 2006-02-24 | ||||||||||||||||
Sponsor Name:University of Birmingham | ||||||||||||||||||
Full Title: Phase II Study of the Tolerability and Efficacy of the Histone Deacetylase Inhibitor Sodium Valproate given in Conjunction with 5-azacytidine and ATRA (all trans retinoic acid ) in Patients with Ac... | ||||||||||||||||||
Medical condition: Patients who have Acute Myeloid Leukaemia (AML) or Myelodysplasia (MDS) will be recruited to this trial | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003369-16 | Sponsor Protocol Number: GWAP19030 | Start Date*: 2020-06-02 |
Sponsor Name:GW Research Ltd. | ||
Full Title: A Randomized, Double-blind, Parallel-group Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants with Schizophrenia Experiencing Inadequate... | ||
Medical condition: Schizophrenia is neurodevelopmental syndrome, results from gradual alterations in brain connectivity. Can persist for years before psychosis emerges. Individuals have a 2 to 3 fold increased risk o... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) PL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-003915-11 | Sponsor Protocol Number: CarniValI (Uni-Koeln-1107) | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:University of Utah | |||||||||||||
Full Title: Phase I/II Trial of Valproic Acid and Carnitine in Infants with Spinal Muscular Atrophy Type I (CARNI-VAL Type I) | |||||||||||||
Medical condition: Spinal Muscular Atrophy Type I in infants | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001017-16 | Sponsor Protocol Number: FARM9A8J83 | Start Date*: 2012-04-16 | ||||||||||||||||
Sponsor Name:IRCCS FONDAZIONE ISTITUTO NEUROLOGICO C. MONDINO | ||||||||||||||||||
Full Title: A randomized controlled trial of generic substitution of antiepileptic drugs | ||||||||||||||||||
Medical condition: Epilepsy or other diseases in which using: carbamazepine, lamotrigine, levetiracetam, oxcarbazepine, topiramate and valproate in mono or politerapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015105-39 | Sponsor Protocol Number: 2008_36 | Start Date*: 2010-01-14 |
Sponsor Name:Centre Hospitalier Universiatire de Lille | ||
Full Title: Etude de phase II évaluant une chimiothérapie combinant doxorubicine, cyclophosphamide, vindésine et acide valproïque dans les cancers bronchiques à petites cellules réfractaires ou récidivant aprè... | ||
Medical condition: les cancers bronchiques à petites cellules | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.